None listed
Conditions
Interventions
Capsules containing plant extract, single daily ingestion.
Capsules containing plant extract and a food ingredient, single daily ingestion.
Placebo capsules not containing plant extract and a food ing
Sponsors
Kirin Company, Limited
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) Individuals aged from 20 to 60 years, when giving the informed consent. (2) Individuals who give the informed consents in writing, after receiving enough explanation of the purpose and details of the study, understanding the study well, and deciding to attend the study with their own will.
Exclusion criteria
Exclusion criteria: (1) Individuals who are under treatment of some disease. (2) Individuals who have possibility of allergy symptoms onset. (3) Individuals who are under treatment of skin disease (e.g., atopic dermatitis). (4) Individuals who are, or are under treatment, or have a history of serious disease (e.g., liver disease, kidney disease, heart disease) or/and thyroid gland disease, adrenal gland disease, and/or metabolic disorder. (5) Individuals who are pregnant or lactating. (6) Individuals who are planned to participate in other clinical study during this study periods.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| skin surface temperature (First observation, Second observation, Third observation) blood flow (First observation, Second observation, Third observation) | — |
Countries
Japan
Contacts
Public ContactMika Miyake
Kirin Company, Limited Research laboratories for health science & food technologies
Outcome results
None listed